New Phage Therapy BX003 in the Pipelines as Possible IBD Treatment

BiomX has created a new phage oral therapy that targets specific bacteria, thought to exacerbate symptoms, in the gut of IBD patients. This new possible treatment is in the pipelines, but has shown promising results in its Phase 1 human trials. This new therapy, called BX003, works by using bacteriophages (phages)which are viruses that infect … Read more